ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 123 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,334 | -74.7% | 565 | -64.4% | 0.00% | – |
| Q2 2023 | $44,713 | +212819.0% | 1,585 | +27.3% | 0.00% | – |
| Q1 2023 | $21 | -12.5% | 1,245 | +2.5% | 0.00% | – |
| Q4 2022 | $24 | -99.9% | 1,215 | -1.9% | 0.00% | – |
| Q3 2022 | $31,000 | -8.8% | 1,238 | +3.2% | 0.00% | – |
| Q2 2022 | $34,000 | -37.0% | 1,200 | +1.7% | 0.00% | – |
| Q1 2022 | $54,000 | -30.8% | 1,180 | -13.2% | 0.00% | -100.0% |
| Q4 2021 | $78,000 | -30.4% | 1,360 | -19.0% | 0.00% | 0.0% |
| Q3 2021 | $112,000 | +25.8% | 1,680 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $89,000 | – | 1,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |